Bacterial Pneumonia Clinical Trial
Official title:
A Phase 3 Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Omadacycline Intravenous (IV)/Oral (PO) to Moxifloxacin IV/PO for Treating Adults Subjects With Community-Acquired Bacterial Pneumonia
The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01570192 -
Clinical Trials to Reduce the Risk of Antimicrobial Resistance
|
Phase 2 | |
Recruiting |
NCT04952337 -
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
|
||
Completed |
NCT02493764 -
Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
|
Phase 3 | |
Completed |
NCT00079885 -
Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
Recruiting |
NCT05629741 -
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101
|
Phase 1 | |
Completed |
NCT05417997 -
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
|
Phase 3 | |
Withdrawn |
NCT00645619 -
Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
|
||
Completed |
NCT00509106 -
Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT00080496 -
Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT03158727 -
Cx611-0204 SEPCELL Study
|
Phase 1/Phase 2 | |
Completed |
NCT00621504 -
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT00124020 -
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
|
Phase 3 | |
Completed |
NCT00081575 -
Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia
|
Phase 3 | |
Completed |
NCT00451386 -
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
|
Phase 2 | |
Recruiting |
NCT03752320 -
Multiplex Polymerase Chain Reaction in Postoperative Pneumonia After Thoracic Surgery
|
||
Active, not recruiting |
NCT04779242 -
Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
|
Phase 3 | |
Completed |
NCT00763620 -
Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter
|
N/A | |
Completed |
NCT00107952 -
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
|
Phase 3 | |
Terminated |
NCT03862040 -
Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia
|
Phase 1 | |
Recruiting |
NCT05531149 -
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
|
Phase 3 |